Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Oral NRX 194204 in Patients With Refractory Malignancies

This study has been terminated.
(Sponsor withdrew study. Accrual not completed)
Sponsor:
Information provided by (Responsible Party):
University of Southern California
ClinicalTrials.gov Identifier:
NCT00630760
First received: February 28, 2008
Last updated: May 19, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2010
  Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)